Oncology PracticeFDA approves new indications for pembrolizumabJuly 1, 2020Patient & Survivor CareBreast CancerCNS/Brain CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid Cancers
Oncology PracticeTreatments linked to death in COVID patients with thoracic cancersJune 29, 2020Lung CancerCOVID-19 Updates
Oncology PracticePersonalized cancer vaccine may enhance checkpoint inhibitor activityJune 25, 2020ImmunotherapyBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersMelanoma
Oncology PracticeImmunotherapy combo improves ORR, PFS in PD-L1+ NSCLCJune 22, 2020Lung CancerASCO Lung Cancer
Oncology PracticeLow-dose CT lung cancer screening still debated, despite evidenceJune 22, 2020Lung Cancer
Oncology PracticeCheckMate 9LA: ‘Doing better’ for stage IV/recurrent NSCLCJune 18, 2020Lung CancerASCO Lung Cancer
Oncology Practice‘Hospital at home’ cuts ED visits and costs for cancer patientsJune 12, 2020Patient & Survivor CareGastroenterologyGynecologic CancerGenitourinary CancerLung CancerASCO Lung CancerGastrointestinal Cancer
Oncology PracticeUpfront stereotactic radiosurgery an option for SCLC brain metsJune 12, 2020Lung Cancer
Oncology PracticeNo OS benefit with gefitinib vs. chemo for EGFR+ NSCLCJune 10, 2020Lung CancerASCO Lung Cancer
Oncology PracticeTepotinib elicits responses in METex14 NSCLCJune 10, 2020Lung CancerASCO Lung Cancer
Oncology PracticeAmerican Cancer Society update: ‘It is best not to drink alcohol’June 9, 2020Preventive CareBreast CancerGastroenterologyGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
